All News #Library
Others
OKYO Pharma Doses First Patient in Neuropathic Pain Trial
23 Oct 2024 //
GLOBENEWSWIRE
Specifica Announces Agreement with Servier and its Subsidiary Symphogen
29 Mar 2023 //
PRESS RELEASE
Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi
02 Jun 2022 //
BUSINESSWIRE

Market Place
Sourcing Support